Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study.

Ben Van Calster; Kirsten Van Hoorde; Lil Valentin; Antonia C Testa; Daniela Fischerova; Caroline Van Holsbeke; Luca Savelli; Dorella Franchi; Elisabeth Epstein; Jeroen Kaijser; Vanya Van Belle; Artur Czekierdowski; Stefano Guerriero; Robert Fruscio; Chiara Lanzani; Felice Scala; Tom Bourne; Dirk Timmerman

doi:10.1136/bmj.g5920

Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study.

Ben Van Calster, Kirsten Van Hoorde, Lil Valentin, Antonia C Testa, Daniela Fischerova, Caroline Van Holsbeke, Luca Savelli, Dorella Franchi, Elisabeth Epstein, Jeroen Kaijser, Vanya Van Belle, Artur Czekierdowski, Stefano Guerriero, Robert Fruscio, Chiara Lanzani, Felice Scala, Tom Bourne, Dirk Timmerman

Research output: Contribution to journal › Article › peer-review

63 Downloads (Pure)

Abstract

To develop a risk prediction model to preoperatively discriminate between benign, borderline, stage I invasive, stage II-IV invasive, and secondary metastatic ovarian tumours.

Original language	English
Pages (from-to)	g5920
Journal	BMJ: British Medical Journal
Volume	349
DOIs	https://doi.org/10.1136/bmj.g5920
Publication status	Published - 2014

Subject classification (UKÄ)

Obstetrics, Gynecology and Reproductive Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1136/bmj.g5920

BMJ__Van_Calster_et_al

http://www.ncbi.nlm.nih.gov/pubmed/25320247?dopt=Abstract

Fingerprint

Dive into the research topics of 'Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study.'. Together they form a unique fingerprint.

Cite this

Van Calster, B., Van Hoorde, K., Valentin, L., Testa, A. C., Fischerova, D., Van Holsbeke, C., Savelli, L., Franchi, D., Epstein, E., Kaijser, J., Van Belle, V., Czekierdowski, A., Guerriero, S., Fruscio, R., Lanzani, C., Scala, F., Bourne, T., & Timmerman, D. (2014). Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study. BMJ: British Medical Journal, 349, g5920. https://doi.org/10.1136/bmj.g5920

@article{70fc53b51f254407a5c277f26ce686c3,

title = "Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study.",

abstract = "To develop a risk prediction model to preoperatively discriminate between benign, borderline, stage I invasive, stage II-IV invasive, and secondary metastatic ovarian tumours.",

author = "{Van Calster}, Ben and {Van Hoorde}, Kirsten and Lil Valentin and Testa, {Antonia C} and Daniela Fischerova and {Van Holsbeke}, Caroline and Luca Savelli and Dorella Franchi and Elisabeth Epstein and Jeroen Kaijser and {Van Belle}, Vanya and Artur Czekierdowski and Stefano Guerriero and Robert Fruscio and Chiara Lanzani and Felice Scala and Tom Bourne and Dirk Timmerman",

year = "2014",

doi = "10.1136/bmj.g5920",

language = "English",

volume = "349",

pages = "g5920",

journal = "BMJ: British Medical Journal",

issn = "1756-1833",

publisher = "BMJ Publishing Group",

}

Van Calster, B, Van Hoorde, K, Valentin, L, Testa, AC, Fischerova, D, Van Holsbeke, C, Savelli, L, Franchi, D, Epstein, E, Kaijser, J, Van Belle, V, Czekierdowski, A, Guerriero, S, Fruscio, R, Lanzani, C, Scala, F, Bourne, T & Timmerman, D 2014, 'Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study.', BMJ: British Medical Journal, vol. 349, pp. g5920. https://doi.org/10.1136/bmj.g5920

Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study. / Van Calster, Ben; Van Hoorde, Kirsten; Valentin, Lil et al.
In: BMJ: British Medical Journal, Vol. 349, 2014, p. g5920.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study.

AU - Van Calster, Ben

AU - Van Hoorde, Kirsten

AU - Valentin, Lil

AU - Testa, Antonia C

AU - Fischerova, Daniela

AU - Van Holsbeke, Caroline

AU - Savelli, Luca

AU - Franchi, Dorella

AU - Epstein, Elisabeth

AU - Kaijser, Jeroen

AU - Van Belle, Vanya

AU - Czekierdowski, Artur

AU - Guerriero, Stefano

AU - Fruscio, Robert

AU - Lanzani, Chiara

AU - Scala, Felice

AU - Bourne, Tom

AU - Timmerman, Dirk

PY - 2014

Y1 - 2014

N2 - To develop a risk prediction model to preoperatively discriminate between benign, borderline, stage I invasive, stage II-IV invasive, and secondary metastatic ovarian tumours.

AB - To develop a risk prediction model to preoperatively discriminate between benign, borderline, stage I invasive, stage II-IV invasive, and secondary metastatic ovarian tumours.

U2 - 10.1136/bmj.g5920

DO - 10.1136/bmj.g5920

M3 - Article

SN - 1756-1833

VL - 349

SP - g5920

JO - BMJ: British Medical Journal

JF - BMJ: British Medical Journal

ER -

Van Calster B, Van Hoorde K, Valentin L, Testa AC, Fischerova D, Van Holsbeke C et al. Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study. BMJ: British Medical Journal. 2014;349:g5920. doi: 10.1136/bmj.g5920